On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


City View Green Holdings Inc. (CSE: CVGR) Enters into New Partnership, Appoints New CEO

  • Company plans to enter the cannabis edible and beverage markets
  • CVGR recently entered into a partnership with a leading Jamaican Blue Mountain coffee company
  • Company has appointed an alcohol beverage industry veteran as its new CEO

Focused on seed-to-retail, City View Green Holdings Inc. (CSE: CVGR) is a vertically integrated cannabis company whose primary objective is to diversify, with an aim of assessing and potentially acquiring targets in the cannabis industry. Once the company has acquired its Cannabis Act license, its plans include the production of high-quality edible products, distillates and water-soluble products for domestic and international CBD-infused beverage markets. The company will incorporate growing, extraction, production and retail operations at its 40,000-square-foot facility in Brantford, Ontario.

City View Green has entered into a partnership with Blue Bean Coffee Ltd., a global representative of the leading Jamaican Blue Mountain coffee farms (http://ibn.fm/hQcvN). Coffee has the potential to play a large role in the edible and consumable cannabis space, and CVGR wanted to partner with Blue Bean Coffee because of the company’s focus on delivering the finest tasting and highest quality coffee products possible.

Five coffee farms with boutique roasting capability make up the network of Blue Bean Coffee’s suppliers, which are nestled in the highest elevations of the Blue Mountains. Only the finest handpicked beans are selected, ensuring that each cup delivers the highest quality of aroma and taste. The goal is to develop and provide the highest-quality and best-tasting THC- and/or CBD-infused coffee in the industry.

In addition to this partnership, CVGR is assembling a highly qualified management team with extensive contacts that will set the company apart from the competition. CVGR’s new CEO, Ian MacDonald, brings with him proven leadership in the international alcohol beverage industry. MacDonald has repeatedly transformed companies in the alcohol beverage space into award-winning, industry-leading organizations.

MacDonald did not come to City View Green lightly. Before making the move, he spent time with the organization to ensure that it was equipped to deliver the type of success toward which he works. Only after meeting the CVGR team, vetting the business model and assessing the company’s ability to differentiate itself from the competition did MacDonald agree to join the team.

“City View Green has arguably the best team in the business,” MacDonald said in a news release when asked what sets the company apart in the cannabis industry. “Our master grower is a former founder of Weed MD, our extraction specialist is one of the most experienced extraction professionals in North America, our QA person has actual cannabis experience, which is rare in a market that is still in its infancy. It’s the team that will set us apart from everyone else.”

Rob Fia, who has led the company from concept to realization, will step down as CEO of CVGR and will be appointed president, working alongside MacDonald to take the company to the next level (http://ibn.fm/S5OiE).

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.